Skip to main content
Fig. 3 | Applied Cancer Research

Fig. 3

From: In vivo antitumor potential of extracts from different parts of Bauhinia variegata linn. Against b16f10 melanoma tumour model in c57bl/6 mice

Fig. 3

Variations in the reduced glutathione (GSH) level in the liver, blood, kidney of mice during melanoma tumor with/with treatment of B. variegata extract. The Tumour GSH was expressed in μ mole/ml of protein in Blood (a); where as in Liver (b) and Kidney (c) expressed by μ mole/g of protein. The data represented Means ± S.E.M. (N = 6 mice) from triplicate experiments. *significantly different from cyclophosphamide group (CP) and Tumour control (TC) group (p < 0.05). BVLE: Bauhinia variegata leaf extract; BVSB: Bauhinia variegata stem bark; BVF: Bauhinia variegata floral extract; CP: cyclophosphamide; TC: Tumour control; SEM: Standard error of mean

Back to article page

Applied Cancer Research

ISSN: 1980-5578